Introduction
============

Plant-based products are considered as the primary source for food additives and ingredients in various natural products. Natural substances are added in the food to enhance its flavour, taste and appearance. Various plant additives are being used for centuries to preserve various health care products and supplements ([@ref-4]; [@ref-5]). According to the World Health Organization (WHO) recommendation, food additives must pass through the safety screen prior to use in any products. Additives in the form of crude plant or extracts are needed to ensure processed food remains safe, and in good condition, a variety of plants extracts contain specific phytochemicals whose biological activities is not known. It is possible that some unwanted phytocompounds might lead to toxic effects or effects products preserving capacity, stability and even the nutritional value of the products ([@ref-59]; [@ref-60]). However, chemical characterization, proper dosing regimen, and insufficient knowledge of the toxicity data constraint limit the usage of additives and herbal medicine ([@ref-20]). Thus, it is the current need to evaluate the possible toxicity of the plant extract and phytocompounds before its therapeutic use.

Lauric acid (LA) is the primary (\>50%) composition of coconut oil ([@ref-48]). It is a medium-chain fatty acid (MCFA) found abundantly in the coconut oil, palm kernel oil and laurel oil, which constitutes about half of the fatty acid ([@ref-10]; [@ref-57]). It is also found in various kinds of foods, such as fruits, seeds, and breast milk ([@ref-3]; [@ref-49]; [@ref-58]). It possesses pleiotropic biological activities, including potent anti-microbial effects ([@ref-16]), beneficial effect on the cardiovascular system (CVS) by increasing high-density lipoproteins (HDL) and reducing blood pressure and heart rate in hypertensive rats ([@ref-2]). Moreover, it also prevents testosterone-induced prostatic hyperplasia ([@ref-9]), and promotes apoptosis in breast and cancerous endometrial cells ([@ref-34]).

Despite various pharmacological properties, scientific evidence on the toxicological and safety profile of LA is not available. This is the first study aimed at investigating the acute toxicity of LA following the Organization of Economic Cooperation and Development (OECD 423) guideline in female Sprague Dawley (SD) rats with slight modifications. In this study, we evaluated numerous parameters, like body weight, food and water intake, haematology, biochemistry, and the histopathological changes in various tissues as shown in [Fig. 1](#fig-1){ref-type="fig"}.

![Study design.](peerj-08-8805-g001){#fig-1}

Materials & Methods
===================

Ethical consideration
---------------------

The acute toxicity study of LA was accomplished in accordance with the guidelines stipulated by the Institutional Animal Care and Use Committee (IACUC), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia with animal ethics approval no: 2018-210605/TAY/R/AA (2018295).

Reagents
--------

Lauric acid (MKCF8837, purity more than 98%) Sigma-Aldrich (St Louis, MO 63103 USA 314-77-5765), Tween-20 (C01-TW121-00, Systerm, UK), normal saline 0.9% (B Braun),10% neutral buffered formalin solution pH 7.4 (R&M, UK), Haematoxylin (Merck, USA) and Eosin (Systerm, UK), Masson trichrome (Abcam150686), Periodic Acid Schiff (Abcam150680) and Picro Sirius Red stain kit (Abcam 150681).

All other chemicals and solvents were of analytical grade.

Experimental animals
--------------------

In this study, eighteen (18) healthy specific pathogens-free (SPF) female SD rats, weighing 240--250 gram (g), age 8--10 weeks old were procured from the Animal Experimental Unit (AEU), Faculty of Medicine, University of Malaya. The AEU facility at the University of Malaya is certified by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC International). All the animals were randomly segregated in three different groups (six animals in each group) and housed in polypropylene cages for seven days to acclimatise laboratory environment prior to the experiments. A consistent environment of 12-hour light/dark cycle, temperature 22 ± 2 °C, and humidity of 50 ± 10% were maintained. The animals were allowed a standard rodent pellet diet and reverse osmosis (RO) water ad libitum throughout the experimental period.

Acute oral toxicity test
------------------------

Acute toxicity study was conducted to assess whether LA produce any mortality or other adverse reactions upon oral administration of dose (300 and 2,000 mg/kg body weight), according to guideline 423 provided by the OECD for the acute toxicity class method procedure ([@ref-41]) with minor amendments ([@ref-42]). Before the experiment, all the animals were carefully weighed, marked, and grouped accordingly:

Group I (*n* = 6): Vehicle (Tween 20/normal saline)-treated

Group II (*n* = 6): Lauric acid-treated, dose 300 mg/kg body weight

Group III (*n* = 6): Lauric acid-treated, dose 2,000 mg/kg body weight.

The LA was dissolved in Tween 20 and diluted with normal saline 0.9% to get the desired dose ([@ref-3]). Animals fasted overnight before dosing, and treatment groups received freshly prepared single doses of LA suspension at 300 and 2,000 mg/kg body weight, while animals in the control group received Tween 20 or normal saline 0.9% suspension equally based on individual body weight. Each gavage volume was 10 mL/kg body weight. All efforts were made to lessen experimental animals' suffering, especially in handling and oral gavage.

Daily observations
------------------

After oral gavage, diet was withheld except water for 2--3 h while animals were monitored individually with special attention in the first half-hour till completion of first 24 h followed by daily cage-side examination for fourteen days for any signs of toxicity including general behavioural in skin, eyes, touch, activeness, and movement changes. All the changes observed were well documented before and after the gavage.

Body weight, food, and water consumption
----------------------------------------

The body weight of the individual animal was carefully noted before and after oral administration of the LA or vehicle, then weekly and lastly on day fifteen (euthanized day). Daily food (g/day), and water (ml/ day) intake was noted on daily basis in all the three groups for fourteen days.

Haematology and biochemical analysis
------------------------------------

On day fourteen, all the animals fasted overnight for 12 h, only water was allowed. All the animals were euthanized in the morning by an intraperitoneal (IP) injection of ketamine (80 mg/kg) & xylazine (7 mg/kg), and blood was collected via micro-capillary tubes from the retro-orbital plexus region into two different sets of test tubes, one containing anticoagulant, ethylene diaminotetraacetic acid (EDTA) for haematological tests including red blood cells (RBC), white blood cells (WBC), platelets count, haemoglobin (Hb), packed cell volumes (PCV), mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), mean corpuscular haemoglobin concentration (MCHC), neutrophil, lymphocytes, monocytes, and eosinophils and the other without additives for clinical biochemistry tests like urea, creatinine, calcium, inorganic phosphate, uric acid, sodium, potassium, chloride, total cholesterol (TC), high-density lipoproteins (HDL), low-density lipoproteins (LDL), triglycerides (TG), total (HDL) ratio, albumin, globulin, albumin-globulin (A/G) ratio, ALP, AST and ALT levels. The collected blood samples were then sent to an ISO-certified blood-testing laboratory.

Measurement of relative organ weight
------------------------------------

Internal organs such as adrenal glands, brain, eyes, heart, kidneys, liver, lungs, ovaries, spleen, stomach, urinary bladder, uterus, and cervix/vagina were isolated through a fine incision in the abdomen at the midline of the euthanized animals. All the harvested tissues were cleaned with phosphate buffer saline (PBS), wiped with clean blotting paper and weighed on a calibrated weighing balance. Relative organ weight (ROW) of all the animals was noted in proportion to body weight according to the following equation:
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Histopathological analysis
--------------------------

Histopathological examination was conducted on the harvested liver, kidney, heart, lungs, brain, spleen, and pancreas in all the animals. Tissues were preserved in 10% neutral, buffered formalin solution for 48 h at 4 °C for histopathological study. Paraffin-embedded specimens of selected tissues were cut into 4--5 µm thick samples and stained with haematoxylin and eosin (H&E), Masson trichrome, Periodic Acid Schiff (PAS) and Picro Sirius Red staining as per the manufacturer protocol detailed in the kits. Later, all the stained tissues were sectioned and observed under the fluorescence compound microscope (40X) (Eclipse Ni-U, Nikon Corporation, Japan).

Statistical analysis
--------------------

All statistical results were expressed as the mean ± standard deviation (SD). The comparison between the treated and control group was performed by a one-way analysis of variance (ANOVA) using statistical software, SPSS package version 22 (IBM, SPSS Statistics, Inc., Chicago, IL, USA) to evaluate the significant differences. The (*p* \< 0.05) compared to the control group was considered statistically significant.

Results
=======

Acute toxicological evaluation and daily observation
----------------------------------------------------

Animals in LA (300 and 2,000 mg/kg body weight) treated group were normal and healthy during fourteen days study period. No signs of mortality or sudden death were observed compared to the untreated group animals. No significant changes in the temperature, skin, eye colour, food and water intake were observed. Furthermore, no behavioural changes or signs of diarrhoea, coma, sedation and tremors were noted as compared to the control group [Table 1](#table-1){ref-type="table"}. Experimental results suggest that LD~50~ of LA should be higher than 2,000 mg/kg body weight.
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###### The behavioural and general response of animals after oral administration of LA.

![](peerj-08-8805-g016)

  **Observation**        **Control**   **LA 300 mg/kg**   **LA 2,000 mg/kg**
  ---------------------- ------------- ------------------ --------------------
  Temperature            n             n                  n
  Skin changes           no            no                 no
  Change eyes colour     no            no                 no
  General physique       n             n                  n
  Diarrhoea              no            no                 no
  Coma                   no            no                 no
  Drowsiness             no            no                 no
  Breathing difficulty   no            no                 no
  Sedation               no            no                 no
  Tremor                 no            no                 no
  Death                  no            no                 no

**Notes.**

*n*normalnonot observed

Effect of LA on body weight, food and water consumption
-------------------------------------------------------

Body weight, food & water intake in the LA treated groups (300 and 2,000 mg/kg body weight) were noted to be non-significant compared to the control group. However, LA treated groups showed slight changes in the body weight, food and water consumption on day fourteen, compared to the untreated group, as shown in [Tables 2](#table-2){ref-type="table"} and [3](#table-3){ref-type="table"}. The mean body weight of the control group was noted as 244.71 ± 3.13 g, whereas treatment groups showed 247.53 ± 2.96, and 240.63 ± 4.76 g, respectively. On day fourteen, the mean body weight gained by the control group was 14.81 ± 0.064 g, while LA treated animals (300 and 2,000 mg/kg body weight) displayed non-significant gain in the body weight (14.93 ± 0.68 and 15.36 ± 0.76 g), respectively. The percentage mean in the body weight of all the treated animals was non-significant in comparison to the control group (*p* \> 0.05), as shown in [Table 2](#table-2){ref-type="table"}.
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###### Effect of LA on body weight (g) assessment.

![](peerj-08-8805-g017)

  **Week**   **Control**     **LA 300 mg/kg**   **LA 2,000 mg/kg**   *F*-value   *P*-value
  ---------- --------------- ------------------ -------------------- ----------- -----------
  Day 0      244.71 ± 3.13   247.53 ± 2.96      240.63 ± 4.76        1.464       0.263
  Week 1%    7.64 ± 0.46     7.52 ± 0.22        7.87 ± 0.35          0.149       0.863
  Week 2%    14.81 ± 0.064   14.93 ± 0.68       15.36 ± 0.76         0.113       0.894

**Notes.**

Values are expressed as the mean standard deviation (*n* = 6 for each group, female). One-way ANOVA (\**p* \< 0.05) significant value.
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###### Effect of LA on food and water consumption.

![](peerj-08-8805-g018)

  **Week**         **Control**      **LA 300 mg/kg**   **LA 2,000 mg/kg**   *F*-value   *P*-value
  ---------------- ---------------- ------------------ -------------------- ----------- -----------
  **Food (g)**                                                                          
  Week 1st         136.35 ± 5.55    150.38 ± 19.65     133.84 ± 9.18        0.265       0.570
  Week 2nd         139.50 ± 13.13   123.07 ± 54.79     142.61 ± 12.82                   
  **Water (ml)**                                                                        
  Week 1st         204.28 ± 23.17   211.42 ± 31.58     200.71 ± 67.23       2.609       0.071
  Week 2nd         184.28 ± 13.36   172.85 ± 7.55      187.14 ± 14.67                   

**Notes.**

Values are expressed as the mean ± standard deviation (*n* = 6 for each group, female). One-way ANOVA (\**p* \< 0.05) significant value.

Moreover, LA administration (300 and 2,000 mg/kg) showed non-significant changes (*p* \> 0.05) in the food and water consumption, compared to the control group, as shown in [Table 3](#table-3){ref-type="table"}.

Effect of LA on relative organ weight
-------------------------------------

The relative organ weight of the harvested tissues---adrenal glands, brain, eyes, heart, kidney, liver, lungs, ovaries, spleen, stomach, urinary bladder, uterus and cervix/vagina, revealed non-significant changes post-LA treatment (300 and 2,000 mg/kg body weight) compared with the control group animals (*p* \> 0.05), as shown in [Table 4](#table-4){ref-type="table"}.
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###### Effect of LA on relative organ weight (g).
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  **Organ**               **Control**     **LA 300 mg/kg**   **LA 2,000 mg/kg**   *F*-value   *P*-value
  ----------------------- --------------- ------------------ -------------------- ----------- -----------
  Adrenal gland (left)    0.018 ± 0.001   0.019 ± 0.002      0.019 ± 0.002        0.638       0.698
  Adrenal gland (right)   0.020 ± 0.004   0.018 ± 0.003      0.019 ± 0.001        0.537       0.595
  Brain                   0.643 ± 0.032   0.626 ± 0.069      0.632 ± 0.051        0.162       0.852
  Eye (left)              0.041 ± 0.002   0.042 ± 0.003      0.044 ± 0.003        1.632       0.228
  Eye (right)             0.043 ± 0.001   0.043 ± 0.002      0.045 ± 0.004        1.218       0.323
  Heart                   0.277 ± 0.016   0.290 ± 0.019      0.286 ± 0.012        0.960       0.405
  Kidney (left)           0.285 ± 0.012   0.300 ± 0.024      0.280 ± 0.025        1.480       0.259
  Kidney (right)          0.288 ± 0.014   0.297 ± 0.020      0.275 ± 0.013        2.640       0.104
  Liver                   2.981 ± 0.254   2.918 ± 0.367      2.931 ± 0.344        0.062       0.940
  Lungs                   0.476 ± 0.038   0.469 ± 0.028      0.502 ± 0.029        1.693       0.217
  Ovary (left)            0.032 ± 0.008   0.031 ± 0.005      0.033 ± 0.010        0.062       0.940
  Ovary (right)           0.033 ± 0.005   0.033 ± 0.009      0.033 ± 0.006        0.003       0.997
  Pancreas                0.292 ± 0.043   0.359 ± 0.074      0.306 ± 0.056        2.117       0.115
  Spleen                  0.220 ± 0.018   0.209 ± 0.027      0.195 ± 0.013        2.284       0.136
  Stomach                 0.754 ± 0.111   0.762 ± 0.184      0.939 ± 0.238        1.890       0.185
  Urinary bladder         0.037 ± 0.003   0.041 ± 0.007      0.037 ± 0.004        0.922       0.419
  Uterus                  0.398 ± 0.054   0.445 ± 0.211      0.258 ± 0.315        2.579       0.109
  Cervix/Vagina           0.081 ± 0.017   0.075 ± 0.011      0.074 ± 0.008        0.445       0.445

**Notes.**

Values are expressed as the mean ± standard deviation (*n* = 6 for each group, female). One-way ANOVA (\**p* \< 0.05) significant value.

Effect of LA on haematology and clinical biochemistry
-----------------------------------------------------

The effect on haematological analysis is summarised in [Table 5](#table-5){ref-type="table"}. Parameters including RBC, WBC, platelets count, Hb, PCV, MCV, MCH, MCHC, neutrophil, lymphocytes, monocytes, and eosinophils shows non-significant changes (*p* \> 0.05) after oral administration of LA (300 and 2,000 mg/kg body weight) when compared with the control animals. Importantly, all the values were within the reference range, compared to the control group.
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###### Effect of LA on haematology.

![](peerj-08-8805-g020)

  **Parameters**        **Control**        **LA 300 mg/kg**    **LA 2,000 mg/kg**   *F*-value   *P*-value
  --------------------- ------------------ ------------------- -------------------- ----------- -----------
  RBCs (10^12^/L)       7.350 ± 0.187      7.616 ± 0.584       7.666 ± 0.216        1.232       0.320
  WBCs (10^9^/L)        3.883 ± 0.491      3.866 ± 1.237       3.533 ± 0.960        0.163       0.851
  Platelets (10^9^/L)   953.333 ± 68.677   865.000 ± 356.083   846.666 ± 154.749    1.091       0.361
  Hb (g/dl)             13.716 ± 0.183     13.783 ± 0.523      13.833 ± 0.265       0.553       0.587
  PCV (HCT%)            44.666 ± 1.210     36.833 ± 18.082     44.500 ± 1.378       0.393       0.682
  MCV fL                52.333 ± 16.366    57.500 ± 2.345      57.333 ± 2.732       0.259       0.775
  MCH pg                18.000 ± 0.894     17.666 ± 1.211      17.500 ± 0.836       0.377       0.692
  MCHC g/dL             31.333 ± 0.816     31.500 ± 0.836      31.166 ± 0.752       0.260       0.775
  Neutrophil (%)        24.000 ± 6.131     25.500 ± 7.582      32.500 ± 5.319       3.002       0.080
  Lymphocyte (%)        64.000 ± 5.966     67.666 ± 7.004      61.833 ± 4.215       1.528       0.249
  Monocytes (%)         4.333 ± 1.632      3.500 ± 1.760       3.500 ± 1.643        0.492       0.621
  Eosinophils (%)       2.500 ± 0.547      2.333 ± 0.516       2.33 ± 0.516         0.200       0.821

**Notes.**

Values are expressed as the mean standard deviation (*n* = 6 for each group, female). One-way ANOVA (\**p* \< 0.05) significant value.

Similarly, the biochemical analysis of liver and renal function tests, including urea, creatinine, calcium, inorganic phosphate, uric acid, sodium, potassium, chloride, TC, HDL, LDL, TG, total HDL ratio, albumin, globulin, A/G ratio, ALP, AST and ALT levels for LA treatment groups were not affected and observed to be normal (non-significant (*p* \> 0.05)), when compared with the control group as presented in [Table 6](#table-6){ref-type="table"}.

10.7717/peerj.8805/table-6

###### Effect of LA on clinical biochemistry.

![](peerj-08-8805-g021)

  **Clinical biochemistry**      **Control**        **300 mg/kg**      **2,000 mg/kg**   *F*-value   *P*-value
  ------------------------------ ------------------ ------------------ ----------------- ----------- -----------
  Urea (mmol/L)                  6.633 ± 1.040      6.966 ± 0.977      8.200 ± 1.240     3.427       0.059
  Creatinine (Umol/L)            36.000 ± 4.898     28.833 ± 13.044    37.000 ± 5.656    1.579       0.239
  Calcium (mmol/L                2.530 ± 0.062      2.500 ± 0.109      2.403 ± 0.095     3.126       0.073
  Inorganic Phosphate (mmol/L)   3.195 ± 0.350      3.401 ± 0.642      3.900 ± 0.536     2.871       0.088
  Uric Acid (mmol/L)             0.211 ± 0.290      0.106 ± 0.048      0.098 ± 0.041     0.813       0.462
  Sodium (mmol/L)                145.00 ± 2.097     145.833 ± 1.471    145.333 ± 2.338   0.263       0.772
  Potassium (mmol/L)             5.566 ± 0.163      5.900 ± 0.433      5.616 ± 0.248     2.105       0.156
  Chloride(mmol/L)               98.500 ± 1.048     99.000 ± 2.449     100.500 ± 2.073   1.711       0.214
  TC (mmol/L)                    2.033 ± 0.436      2.300 ± 0.517      1.966 ± 0.307     1.012       0.387
  HDL(mmol/L)                    0.623 ± 0.082      0.640 ± 0.089      0.590 ± 0.098     0.474       0.632
  LDL (mmol/L)                   0.868 ± 0.198      0.933 ± 0.377      0.733 ± 0.398     0.550       0.588
  TG (Umol/L)                    1.783 ± 0.231      1.483 ± 0.487      1.116 ± 0.636     2.879       0.087
  Total HDL Ratio                3.383 ± 0.231      3.516 ± 0.444      3.400 ± 0.236     0.309       0.739
  Total protein (g/dL)           70.833 ± 2.926     71.500 ± 3.507     66.833 ± 3.816    3.236       0.068
  Albumin (g/dL)                 42.166 ± 4.445     44.500 ± 4.888     43.333 ± 3.076    0.461       0.639
  Globulin(g/dL)                 24.333 ± 1.211     25.333 ± 1.211     23.666 ± 0.816    3.519       0.056
  A/G ratio                      1.800 ± 0.894      1.800 ± 0.109      1.833 ± 0.121     0.192       0.827
  AP (IU/L)                      53.666 ± 5.750     57.166 ± 11.669    68.33 ± 25.453    1.293       0.303
  SGOT /AST (IU/L)               165.166 ± 10.703   200.166 ± 35.204   174.33 ± 18.250   3.315       0.056
  SGPT /ALT(IU/L)                36.666 ± 1.966     36.000 ± 3.741     40.500 ± 19.065   0.278       0.761

**Notes.**

Values are expressed as the mean ± standard deviation (*n* = 6 for each group, female). One-way ANOVA (\**p* \< 0.05) significant value.

Effects of LA on Histopathology of internal organs
--------------------------------------------------

The histopathological analysis involves macroscopic and microscopic examination of processed and fixed tissues to visualise various components and structural alterations in the tissues ([@ref-29]; [@ref-32]). H&E staining is the most common and widely used technique to essentially identify morphological changes during diagnosis and screening of any malignancies in the tissues ([@ref-27]). However, Masson trichrome staining remains reliable for the cytoplasm, which gives in-depth and selective detail about the connective tissue ([@ref-56]). PAS staining assesses the changes in glycogen content within muscle fibre sections ([@ref-6]; [@ref-24]). Moreover, the collagen content is analysed with the help of Picro Sirius Red staining, which provides a clear understanding of collagen accumulation in the tissues ([@ref-35]).

In brief, macroscopic analysis of liver sections ([Fig. 2](#fig-2){ref-type="fig"}) in LA-treated rats (300 and 2,000 mg/kg body weight) displays no alterations in the colour or texture, importantly no changes to hepatocytes, hepatic sinusoids, central vein, and portal triad were observed when compared with the control group ([Fig. 3](#fig-3){ref-type="fig"}). Kidney showed no structural degeneration, and colour changes in the renal cortex and tubules, without any tubular necrosis and inflammation in LA-treated animals compared to untreated animals, as displayed ([Figs. 4](#fig-4){ref-type="fig"} and [5](#fig-5){ref-type="fig"}). The photomicrographs of the heart ([Figs. 6](#fig-6){ref-type="fig"} and [7](#fig-7){ref-type="fig"}) tissue showed a normal size of myocardial fibre and filaments when compared with the control group. Lung tissues ([Figs. 8](#fig-8){ref-type="fig"} and [9](#fig-9){ref-type="fig"}) appeared to be normal, with no abnormal changes noted in colour. Moreover, microscopic observation displayed thin inter-alveolar septa, clear alveoli and alveolar sacs with the absence of inflammatory cells, including neutrophils, or thickening of alveolar septa, when compared with the untreated group. Furthermore, brain ([Figs. 10](#fig-10){ref-type="fig"} and [11](#fig-11){ref-type="fig"}) tissues showed normal morphology with the regular shape of the pyramidal neuron and uniform distribution of glial cells in LA-treated and control animals. Macroscopic texture ([Figs. 12](#fig-12){ref-type="fig"} and [13](#fig-13){ref-type="fig"}) exhibited normal and regular appearance with white and red pulp without any sign of apoptotic, necrotic lesions or megakaryocytosis compared with the control group. Microscopic appearance of the pancreas ([Figs. 14](#fig-14){ref-type="fig"} and [15](#fig-15){ref-type="fig"}) appeared with healthy acinar, clear round or oval-shaped Islets cells in cluster form, with lightly stained cytoplasm in the LA-treatment and control animals. Thus, the study results suggest that treatment with minimum and maximum doses of LA (300 & 2,000 mg/kg body weight) did not cause any tissue damage or morphological alteration at the cellular level.

![Macroscopic view of liver tissues of female SD rats in acute oral toxicity study (A) Normal control, (B) LA 300 mg/kg, (C) LA 2,000 mg/kg.\
LA treated animals presenting normal reddish colour closed to the normal control group, after single oral doses of LA (300 mg/kg and 2,000 mg/kg).](peerj-08-8805-g002){#fig-2}

![Microscopic analysis of liver tissues of female SD rats in acute oral toxicity study, presenting normal morphology after single oral doses of LA (300 mg/kg and 2,000 mg/kg).\
H&E (A), Masson trichrome (B), PAS (C), and Picro Sirius Red (D). 40× original magnification.](peerj-08-8805-g003){#fig-3}

Discussion
==========

Toxicological studies of plant-based ingredients or food additives are important to ensure processed food remains safe and in good condition throughout its preservation to avoid any disease conditions. Herbs or plants additives used in dietary supplements, nutraceuticals, should be investigated for toxicity, despite their traditional claims ([@ref-26]; [@ref-36]).

Lauric acid revealed various pharmacological activities, but its safety profile still remains unevaluated. The current study is undertaken to screen the safety, and toxicity of LA at two different dose levels in normal rats, following OECD 423 guidelines.

![Macroscopic view of kidneys of female SD rats in acute oral toxicity study, presenting normal shape and appearance after single oral doses of LA (300 mg/kg and 2,000 mg/kg) (A) Normal control, (B) LA 300 mg/kg, (C) LA 2,000 mg/kg.](peerj-08-8805-g004){#fig-4}

![Microscopic analysis of kidney tissues of female SD rats in acute oral toxicity study, presenting normal morphology after single oral doses of LA (300 mg/kg and 2,000 mg/kg).\
H&E (A), Masson trichrome (B), PAS (C), and Picro Sirius Red (D). 40× original magnification.](peerj-08-8805-g005){#fig-5}

![Macroscopic view of heart of female SD rats in acute oral toxicity study, presenting normal shape and appearance after single oral doses of LA (300 mg/kg and 2,000 mg/kg) (A) Normal control, (B) LA 300 mg/kg, (C) LA 2,000 mg/kg.](peerj-08-8805-g006){#fig-6}

No morbidity or mortality was noticed in LA-treated animals throughout fourteen days of the experimental period. Moreover, in line with previous study of [@ref-8], no changes were observed in general behaviour of treated animals when compared with the control group, suggesting that oral ingestion of LA neither cause any alterations nor produced any internal changes in female SD rats with doses up to 2,000 mg/kg body weight.

Body weight changes are the basic parameter which indicates the health status of animals. However, abrupt variations in the body weight indicate the toxic nature of the chemicals or drugs ([@ref-23]). In this study, LA treatment and control group recorded a normal gain in body weight, indicating, LA does not cause any physiological alterations that affects the normal growth in the animals, which is in agreement with the previous study published by [@ref-14]. Similarly, organ weight variation is the fundamental and perceptive factor correlating organ to body weight index, which is important and critical in determining drug toxicity linked to treatment-related effects ([@ref-47]). It is believed that medicinal plants in high dose could cause toxic or even lethal effects when administered in vivo ([@ref-50]; [@ref-51]). Results from this study showed no difference in ROW in the treatment group when compared to control group, which indicates that LA is safer to the internal organs, supported by an earlier study published by [@ref-43]. Studies have proven that ingesting toxic substances could suppress appetite, thus leading to less caloric intake ([@ref-37]). During fourteen days observation period, no significant changes were noted in water and food consumption ([Table 5](#table-5){ref-type="table"}), which shows that LA has no effect on the appetite of the animals, which is in line with the previous findings published by [@ref-18]; [@ref-54].

![Microscopic analysis of heart tissues of female SD rats in acute oral toxicity study, presenting normal morphology after single oral doses of LA (300 mg/kg and 2,000 mg/kg).\
H&E (A), Masson trichrome (B), PAS (C), and Picro Sirius Red (D). 40× original magnification.](peerj-08-8805-g007){#fig-7}

![Macroscopic view of lungs of female SD rats in acute oral toxicity study, presenting normal shape and appearance after single oral doses of LA (300 mg/kg and 2,000 mg/kg) (A) Normal control, (B) LA 300 mg/kg, (C) LA 2,000 mg/kg.](peerj-08-8805-g008){#fig-8}

![Microscopic analysis of lungs tissues of female SD rats in acute oral toxicity study, presenting normal morphology after single oral doses of LA (300 mg/kg and 2,000 mg/kg).\
H&E (A), Masson trichrome (B), PAS (C), and Picro Sirius Red (D). 40× original magnification.](peerj-08-8805-g009){#fig-9}

![Macroscopic view of brain of female SD rats in acute oral toxicity study, presenting normal shape and appearance after single oral doses of LA (300 mg/kg and 2,000 mg/kg) (A) Normal control, (B) LA 300 mg/kg, (C) LA 2,000 mg/kg.](peerj-08-8805-g010){#fig-10}

![Microscopic analysis of brain tissues of female SD rats in acute oral toxicity study, presenting normal morphology after single oral doses of LA (300 mg/kg and 2,000 mg/kg).\
H&E (A), Masson trichrome (B), PAS (C), and Picro Sirius Red (D). 40× original magnification.](peerj-08-8805-g011){#fig-11}

![Macroscopic view of spleen of female SD rats in acute oral toxicity study, presenting normal shape and appearance after single oral doses of LA (300 mg/kg and 2,000 mg/kg) (A) Normal control, (B) LA 300 mg/kg, (C) LA 2,000 mg/kg.](peerj-08-8805-g012){#fig-12}

![Microscopic analysis of spleen tissues of female SD rats in acute oral toxicity study, presenting normal morphology after single oral doses of LA (300 mg/kg and 2,000 mg/kg).\
H&E (A), Masson trichrome (B), PAS (C), and Picro Sirius Red (D). 40× original magnification.](peerj-08-8805-g013){#fig-13}

![Macroscopic view of pancreas of female SD rats in acute oral toxicity study, presenting normal shape and appearance after single oral doses of LA (300 mg/kg and 2,000 mg/kg) (A) Normal control, (B) LA 300 mg/kg, (C) LA 2,000 mg/kg.](peerj-08-8805-g014){#fig-14}

![Microscopic analysis of pancreas tissues of female SD rats in acute oral toxicity study, presenting normal morphology after single oral doses of LA (300 mg/kg and 2,000 mg/kg).\
H&E (A), Masson trichrome (B), PAS (C), and Picro Sirius Red (D). 40× original magnification.](peerj-08-8805-g015){#fig-15}

The haematopoietic system is crucial in the production of blood cells that accelerate metabolic functions and enhance normal proliferation in the living organism which act and delineate as a vital tool. This system is profound and directly or indirectly susceptible to chemical-induced injury, affecting physiological and pathological status in both humans and animals ([@ref-15]; [@ref-55]). In the current findings, LA administration indicate non-significant changes in the essential blood cells and related parameters RBC, WBC, platelets count, Hb PCV, Mean MCV, MCH, MCHC, Neutrophil, Lymphocyte, Monocytes and Eosinophils, suggesting non-toxic nature of LA on haematological parameters and substantiating an understanding of normal haematopoiesis, which is in line with the previous findings published by [@ref-21] and [@ref-52].

The liver is the central metabolic organ playing a key role in body metabolic functions where drug and chemical metabolism, biotransformation and detoxification occurs ([@ref-22]). When hepatic cellular damage occurs due to hepatotoxic substances, the sensitive markers including transaminase serum enzymes ALT & AST start releasing from the cytosol and translocate into the bloodstream, leading to mild or severe liver injury ([@ref-26]; [@ref-30]; [@ref-46]). In our study, LA did not elevate these transaminase enzymes, considering non-toxic nature of LA at different dose levels. Similar findings were noted by [@ref-40], where oral administration of the geraniin-enriched extract at 2,000 mg/kg body weight did not affect the biochemical parameters. Similarly, LA treatment did not change renal functions including serum creatinine and urea levels, which are used as an essential index to estimate renal damage ([@ref-7]; [@ref-38]; [@ref-39]). The elevated level of creatinine and urea in the blood displays malfunctioning of the kidney ([@ref-12]; [@ref-25]; [@ref-33]). In addition, serum electrolyte levels of LA treated animals observed to be in normal ranges. Overall, biochemical parameters are in line with previous reports of [@ref-11] and [@ref-53].

Histopathological investigation plays a significant role in determining tissue morphology through microscopical evaluations. The analysis of internal organs are identical and consider as the prime safety tool to determine any histological perturbations or deformities in the tissues ([@ref-13]; [@ref-44]). Therefore, the histopathological judgements concrete the haematological and biochemical findings and further substantiate the biological response factors ([@ref-31]). Histopathological examination (macroscopic and microscopic) of internal organs including liver, kidney, heart, lungs, brain, spleen, and pancreas revealed a regular architecture, no morphological alterations were observed in LA treatment groups compared to the control group. Tissue degeneration or anomalies leading to necrosis, apoptosis or fibrosis are the basic parameters to determine toxicity in internal organs ([@ref-17]).

The liver is the metabolic connective tissue which controls biliary and vascular traffic. Administration of LA at the minimum and maximum dose did not cause structural degeneration or accumulation in the liver tissues, displaying normal clusters of hepatocytes and parenchymal cells housed in cord-like arrangements. In this study, microscopical features of liver tissue is in agreement with the published data by [@ref-32] who postulated that changes to these cellular events might potentially be associated with the accumulation of exogenous chemicals and their metabolites may cause dose-dependent toxicity or damage to the liver ([@ref-19]).

Similarly, LA administration did not alter kidney tissue, which showed organised pyramidal structure without any tubular necrosis and inflammation in the cortex and inner portion of the medulla region. However, the toxic effect of any compound on the kidney is demonstrated by changes in the serum creatinine or urea level ([@ref-28]). Finding from this study reveals the harmless nature of LA on renal function by establishing the outcomes from histopathological analysis, which did not notice lesion or necrotic marks upon LA administration. Likewise, LA treatment on heart tissues displayed normal architecture of myocardial fibre and filaments which is in line with [@ref-29] findings, who reported no morphological changes in heart tissues upon treatment with the phytocompounds. In a similar way, lungs of LA-treated animals showed no treatment-related morphological alterations, and our findings are in agreement with [@ref-1] who reported that no toxicological alteration was noted upon Arjunolic acid treatment in normal female SD rats. Furthermore, brain tissues showed normal morphology upon LA treatment, with no alterations to the cell types approaching through normal characteristics based on tissue pattern recognition, including neurons, glia, and microglia cells without any modulation to perivascular region. Thus, our study is supported by previous findings by [@ref-45] who reported no structural and morphological changes in brain tissues following treatment with ethanolic extract of *Centella asiatica* plant. Moreover, LA treatment did not alter pancreas and spleen tissue which shows normal architecture, as we know rodent pancreas and spleen are diffused and soft compare to human tissues, which is in line with the previously published study by [@ref-44] that reveals no morphological variation in tissues of control and hydroalcoholic extract of polyherbal treatment groups.

The present study expressed that oral administration of LA did not cause any morbidity or mortality at the selected doses, and LD50 values were greater than 2,000 mg/kg body weight. Based on the current findings, LA should remain in toxicity class 5, which exhibited the lowest toxicity (LD50 \> 2,000 mg/kg body weight) as per the OECD 423 guideline, under chemical labelling and classification ([@ref-41]).

Conclusions
===========

The findings of the current study showed that LA did not cause any significant changes upon oral administration up to 2,000 mg/kg body weight in female SD rats; no treatment-related signs of toxicity or mortality were noted. Moreover, histopathological examination exhibits no remarkable changes in the harvested tissues. Thus, it provides basic information on the toxicity and safety profile of LA, indicating low toxicity in the analysed parameters. This study could be helpful in the selection of dosages for future subacute or chronic disease model. However, in future, well-designed treatment strategies on pharmacological aspects should be carried out to set a clear understanding of safety and efficacy. Therefore, further validation on LA would enable to decide effective therapeutic dose prior to its long-term treatment as well as before the development of any health care products.
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